marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
AgeX Therapeutics Financial Statements 2011-2024 | AGE
Annual Financial Statements AgeX Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
14.1 K | 679 | 30.4 M | 65.5 M | 52.6 M | 137 M | - | 132 M | - | - | - | - | - |
Shares |
1.08 K | 1.08 K | 37.9 M | 37.7 M | 37.3 M | 34.9 M | - | 35.8 M | - | - | - | - | - |
Historical Prices |
13 | 0.63 | 0.803 | 1.74 | 1.37 | 3.87 | - | - | - | - | - | - | - |
Net Income |
-14.8 M | -10.5 M | -8.68 M | 2 M | -12.2 M | -7.5 M | -6.58 M | - | - | - | - | - | - |
Revenue |
142 K | 34 K | 144 K | 1.87 M | 1.73 M | 1.4 M | 1.4 M | - | - | - | - | - | - |
Cost of Revenue |
40 K | 13 K | 19 K | 26 K | 244 K | 364 K | 168 K | - | - | - | - | - | - |
Gross Profit |
102 K | 21 K | 125 K | 1.71 M | 1.48 M | 1.03 M | 1.24 M | - | - | - | - | - | - |
Operating Income |
-9.89 M | -6.98 M | -7.93 M | -10.1 M | -12.6 M | -11.2 M | -6.66 M | - | - | - | - | - | - |
Interest Expense |
4.9 M | 3.34 M | 1.1 M | 105 K | 294 K | - | - | - | - | - | - | - | - |
EBITDA |
-9.76 M | -6.84 M | -7.8 M | -9.4 M | -11.6 M | -10.7 M | -7.74 M | - | - | - | - | - | - |
Operating Expenses |
10.1 M | 7 M | 8.16 M | 12.4 M | 14 M | 12.3 M | 9.65 M | - | - | - | - | - | - |
General and Administrative Expenses |
9.33 M | 5.97 M | 6.71 M | 7.4 M | 8.14 M | 5.65 M | 3.87 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement AgeX Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
8.85 M | 8.51 K | 2.79 M | 2.41 M | 2.19 M | 2.17 K | 2.17 M | 37.9 M | 37.9 K | 37.9 K | 37.9 M | 37.9 M | 37.9 M | 37.9 K | 37.7 M | 37.7 M | 37.7 M | 37.7 M | 37.7 M | 37.6 M | 37.6 K | 37.6 M | 36.1 K | 35.8 M | 35.8 K | 34.2 M | 33.8 M | 33.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
1.41 M | 5.2 M | -9.44 M | - | 1.75 M | 808 K | 1.66 M | - | -2.44 M | -2.62 M | -2.71 M | - | -1.96 M | -2.47 M | -2.09 M | - | -2.54 M | 2 M | -3.19 M | - | -3.22 M | -3.09 M | -3.13 M | - | -2.15 M | -1.93 M | -235 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
14 K | 51 K | 5 K | - | 29 K | 7 K | 30 K | - | 9 K | 12 K | 5 K | - | 24 K | 37 K | 56 K | - | 69 K | 45 K | 89 K | - | 411 K | 380 K | 388 K | - | 380 K | 464 K | 239 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | 33 K | 5 K | 1 K | - | 5 K | 6 K | 1 K | - | 2 K | 13 K | 3 K | - | 17 K | 3 K | 1 K | - | 49 K | 53 K | 63 K | - | -4 K | 79 K | 109 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | 34 K | 4 K | 9 K | - | 4 K | 6 K | 4 K | - | 22 K | 24 K | 53 K | - | 52 K | 42 K | 88 K | - | 362 K | 327 K | 325 K | - | 384 K | 385 K | 130 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-5.31 M | -3.87 M | -2.32 M | - | -1.46 M | -945 K | -962 K | - | -1.55 M | -1.59 M | -2.05 M | - | -1.67 M | -2.2 M | -2.19 M | - | -2.4 M | -2.37 M | -3.01 M | - | -3.28 M | -3.44 M | -3.12 M | - | -2.2 M | -2.13 M | -3.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
42 K | - | 99 K | - | 105 K | 792 K | 86 K | - | 923 K | 863 K | 571 K | - | 285 K | 4 K | 437 K | - | -12 K | 1 K | 5 K | - | 48 K | 257 K | -28 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | -3.84 M | -2.3 M | - | -1.43 M | -927 K | -949 K | - | -1.52 M | -1.56 M | -2.02 M | - | -1.58 M | -2.17 M | -1.96 M | - | -2.17 M | -2.14 M | -2.78 M | - | -3.16 M | -3.33 M | -3.11 M | - | -2.18 M | -2.12 M | -3.54 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
5.33 M | 3.92 M | 2.33 M | - | 1.49 M | 952 K | 992 K | - | 1.55 M | 1.6 M | 2.06 M | - | 1.7 M | 2.23 M | 2.35 M | - | 2.45 M | 2.41 M | 3.1 M | - | 3.64 M | 3.77 M | -3.45 M | - | -2.59 M | 2.52 M | 3.68 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.91 M | 2.32 M | 1.22 M | - | 889 K | 473 K | 593 K | - | 1.39 M | 1.34 M | 1.66 M | - | 1.42 M | 1.75 M | 2.02 M | - | 1.8 M | 1.48 M | 1.88 M | - | 2.19 M | 2.12 M | 2.11 M | - | 1.25 M | 1.14 M | 1.29 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency